Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study.

被引：0
|
作者：
Herrera, Alex Francisco
Tracy, Samuel
Sehn, Laurie Helen
Jardin, Fabrice
Lenz, Georg
Trneny, Marek
Salles, Gilles A.
Flowers, Christopher
Tilly, Herve
Sharman, Jeff Porter
Friedberg, Jonathan W.
Balasubramanian, Sandhya
Raghavan, Vibha
Hirata, Jamie H.
Lee, Calvin
Jiang, Yanwen
Morschhauser, Franck
机构：
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[2] Ctr Henri Becquerel, Rouen, France
[3] Univ Rouen, Rouen, France
[4] Univ Hosp Munster, Munster, Germany
[5] Charles Univ Prague, Gen Hosp, Prague, Czech Republic
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
[7] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[8] Willamette Valley Canc Inst & Res Ctr, US Oncol Res, Eugene, OR USA
[9] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA
[10] Hoffmann Roche Ltd, Mississauga, ON, Canada
[11] Univ Lille, Ctr Hosp Univ, Lille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7523
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk profiling of patients (pts) with previously untreated Diffuse Large B-Cell Lymphoma (DLBCL) by measuring circulating tumor DNA (ctDNA): 3-year update of the POLARIX study
    Oellerich, T.
    Lenz, G.
    Herrera, A. F.
    McCord, R.
    Kimes, P.
    Jardin, F.
    Trneny, M.
    Flowers, C. R.
    Sehn, L. H.
    Salles, G.
    Sharman, J. P.
    Tilly, H.
    Friedberg, J. W.
    Herbaux, C.
    Matasar, M.
    Haioun, C.
    Tracy, S.
    Hirata, J.
    Lee, C.
    Jiang, Y.
    Morschhauser, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 24 - 25
  • [2] Risk Profiling of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) By Measuring Circulating Tumor DNA (ctDNA): Results from the POLARIX Study
    Herrera, Alex F.
    McCord, Ronald
    Kimes, Patrick
    Jardin, Fabrice
    Lenz, Georg
    Trneny, Marek
    Flowers, Christopher R.
    Sehn, Laurie H.
    Salles, Gilles
    Sharman, Jeff P.
    Tilly, Herve
    Friedberg, Jonathan W.
    Herbaux, Charles
    Matasar, Matthew J.
    Haioun, Corinne
    Tracy, Samuel
    Hirata, Jamie
    Lee, Calvin
    Jiang, Yanwen
    Morschhauser, Franck
    BLOOD, 2022, 140 : 1297 - 1300
  • [3] Subgroup analysis of elderly patients (pts) with diffuse large B-cell lymphoma (DLBCL) in the phase 3 POLARIX study.
    Hu, Bei
    Reagan, Patrick Michael
    Sehn, Laurie Helen
    Sharman, Jeff Porter
    Hertzberg, Mark
    Zhang, Huilai
    Kim, Austin Injae
    Herbaux, Charles
    Molina, Lysiane
    Maruyama, Dai
    Smolewski, Piotr
    Stenner, Frank
    Craine, Veronica
    Kothari, Rucha
    Hirata, Jamie H.
    Sahin, Deniz
    Sugidono, Matthew Dean Sei
    Lee, Calvin
    Tilly, Herve
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Circulating tumor DNA (ctDNA) in B-cell lymphoma
    Scherer, Florian
    Kurtz, David M.
    Newman, Aaron M.
    Stehr, Henning
    Craig, Alexander F. M.
    Esfahani, Mohammad S.
    Lovejoy, Alexander F.
    Chabon, Jacob J.
    Klass, Daniel M.
    Green, Michael R.
    Liu, Chih L.
    Zhou, Li
    Glover, Cynthia
    Visser, Brendan C.
    Poultsides, George A.
    Advani, Ranjana H.
    Maeda, Lauren S.
    Gupta, Neel K.
    Davis, R. Eric
    Levy, Ronald
    Ohgami, Robert S.
    Kunder, Christian A.
    Rossi, Davide
    Westin, Jason
    Diehn, Maximilian
    Alizadeh, Ash A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 16 - 17
  • [5] Comparison of statistical methods for extrapolating survival in previously untreated diffuse large B-cell lymphoma: results based on the POLARIX study
    Ho, Rodrigo S.
    Launonen, Aino
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1178 - 1189
  • [6] Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)
    Nakashima, J.
    Cruz-Chamarro, R.
    Laborde, J.
    Kim, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E479 - E479
  • [7] Outcomes by BCL2 and MYC expression and rearrangements in untreated diffuse large B-cell lymphoma (DLBCL) from the POLARIX trial.
    Morschhauser, Franck
    Jiang, Yanwen
    Jardin, Fabrice
    Herrera, Alex Francisco
    Sehn, Laurie Helen
    Herbaux, Charles
    Flowers, Christopher
    Phillips, Tycel Jovelle
    Guillermo, Armando Lopez
    Diefenbach, Catherine S. Magid
    Gregory, Gareth
    Kim, Austin Injae
    Barbui, Anna Maria
    Balasubramanian, Sandhya
    Harris, Will
    Hirata, Jamie
    Paulson, Joseph N.
    Lee, Calvin
    Lenz, Georg
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Outcomes in patients over 60 years old with previously untreated diffuse large B-cell lymphoma (DLBCL) from a single centre
    Walsh, B.
    Davidson, K.
    Davies, J. D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 36 - 36
  • [9] A Proposed Prognostic Score Including Circulating Free DNA (ctDNA) Concentration in Diffuse Large B-Cell Lymphoma (DLBCL): Single Centre Study
    Jamal, Esraa
    Elbogdady, Mohamed
    Saleh, Layla
    Shamaah, Sameh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S454 - S455
  • [10] Clonal Ig DNA Detection In Plasma From Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL)
    Wagner-Johnston, Nina
    Bartlett, Nancy L.
    Payton, Jacqueline E.
    Trinkaus, Kathryn
    Sharma, Akash
    Timm, Justina
    Ambinder, Richard F.
    BLOOD, 2010, 116 (21) : 1288 - 1288
12345